Literature DB >> 31373353

Functional association of a CD40 gene single-nucleotide polymorphism with the pathogenesis of coronary heart disease.

Cheryl S Sultan1, Michael Weitnauer2, Martin Turinsky1, Thorsten Kessler3, Maik Brune4, Christian A Gleissner5, Florian Leuschner5, Andreas H Wagner1, Markus Hecker1.   

Abstract

AIMS: Endothelial dysfunction is a major contributor to the pathogenesis of atherosclerosis. CD40-CD40 ligand interactions confer a pro-inflammatory phenotype to endothelial cells (ECs). Recently, a thymine to cytosine transition (-1T>C) in the Kozak sequence of the CD40 gene (rs1883832) has been associated with coronary heart disease (CHD) in an Asian population. As there are no reports yet regarding its role in other ethnic groups, this study determines if the -1T>C single-nucleotide polymorphism (SNP) could be a risk factor for CHD in Caucasians by performing an association study and elucidates its functional consequence in cultured ECs. METHODS AND
RESULTS: Molecular and biochemical techniques, cell adhesion assays were used for genotype-stratified human EC characterization. SNP distribution in Caucasians was examined in a hospital-based case-control CHD study and serum levels of soluble CD40 (sCD40) were quantified by ELISA. The SNP in the CD40 gene affected baseline CD40 protein abundance on ECs. There was a genotype-dependent difference in CD40-mediated expression of pro-inflammatory genes. Monocyte adhesion was highest on the surface of cells homozygous for the C allele. Homozygosity for the C allele was associated with significant 2.32-fold higher odds of developing CHD as compared to TT genotype carriers. sCD40 plasma levels were genotype-dependently elevated in CHD patients, indicating a possible prognostic value.
CONCLUSION: The C allele of the CD40 SNP provokes a pro-inflammatory EC phenotype, compensated by an enhanced CD40 shedding to neutralize excess CD40 ligand. Homozygosity for the C allele is the cause for a genetic susceptibility to atherosclerosis and its sequelae. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  CD40; Coronary heart disease; Endothelial cells; Functional genomics; Single-nucleotide polymorphism

Year:  2020        PMID: 31373353     DOI: 10.1093/cvr/cvz206

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

1.  Translational enhancement by base editing of the Kozak sequence rescues haploinsufficiency.

Authors:  Chiara Ambrosini; Eliana Destefanis; Eyemen Kheir; Francesca Broso; Federica Alessandrini; Sara Longhi; Nicolò Battisti; Isabella Pesce; Erik Dassi; Gianluca Petris; Anna Cereseto; Alessandro Quattrone
Journal:  Nucleic Acids Res       Date:  2022-10-14       Impact factor: 19.160

Review 2.  Genetics and epigenetics of autoimmune thyroid diseases: Translational implications.

Authors:  Hanna J Lee; Mihaela Stefan-Lifshitz; Cheuk Wun Li; Yaron Tomer
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2022-04-11       Impact factor: 5.667

3.  COMP (Cartilage Oligomeric Matrix Protein) Neoepitope: A Novel Biomarker to Identify Symptomatic Carotid Stenosis.

Authors:  Joakim Sandstedt; Karin Vargmar; Kristina Björkman; Ulla Ruetschi; Göran Bergström; Lillemor Mattsson Hultén; Eva Skiöldebrand
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-01-21       Impact factor: 8.311

4.  The effect of CYP7B1 polymorphisms on the risk of coronary heart disease in Hainan Han population.

Authors:  Tiebiao Liang; Xianbo Zhang; Anshan Liang; Haiqing Wu; Qi Wang; Jun He; Ming Long; Tianbo Jin
Journal:  BMC Med Genomics       Date:  2021-09-07       Impact factor: 3.063

Review 5.  CD40/CD40L and Related Signaling Pathways in Cardiovascular Health and Disease-The Pros and Cons for Cardioprotection.

Authors:  Steffen Daub; Esther Lutgens; Thomas Münzel; Andreas Daiber
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

Review 6.  The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease.

Authors:  Laura A Bosmans; Lena Bosch; Pascal J H Kusters; Esther Lutgens; Tom T P Seijkens
Journal:  J Cardiovasc Transl Res       Date:  2020-03-28       Impact factor: 4.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.